PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
EBIT growth of 100.00% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
94.20%
Operating income growth of 94.20% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
94.81%
Net income growth of 94.81% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
98.22%
EPS growth of 98.22% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
98.22%
Diluted EPS growth of 98.22% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
200.00%
Share change of 200.00% while Healthcare median is zero. Walter Schloss would see if the modest difference matters long-term.
200.00%
Diluted share change of 200.00% while Healthcare median is zero. Walter Schloss might see a slight difference in equity issuance policy.
No Data
No Data available this quarter, please select a different quarter.
12.59%
OCF growth of 12.59% while Healthcare is zero. Walter Schloss might see a modest positive difference, which can compound over time.
12.59%
FCF growth of 12.59% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
66.67%
BV/share growth of 66.67% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
SG&A decline while Healthcare grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.